Abstract
Gene expression profiling using microarrays and SAGE is a widely used technology to elucidate important aspects of epithelial ovarian cancer (EOC) in order to improve the clinical management of this disease: Despite the high degree of morphological heterogeneity, epithelial ovarian cancer gene expression profiling reflects morphology and biological behaviour. Based on multiple studies, gene expression profiling results can be used to stratify the four different subtypes of EOC, namely serous papillary, mucinous, endometrioid, and clear cell carcinoma, but some overlapping gene expression was also noted. An aneuploid DNA content is a frequent phenomenon in EOC as well as in other solid tumours. However, when differential RNA expression and the DNA copy number as measured by comparative genomic hybridisation (CGH) were compared, the level of concordance was not significant in most studies. The reason for this will mostly lie in the low resolving power of currently used CGH methods and might improve with a wider access to arrayCGH. Several novel candidate markers for the early detection of EOC have been identified by gene expression profiling and examples that have been validated by ELISA on the protein level in serum from EOC patients and healthy controls are discussed. The information from gene expression profiling experiments is now being overlaid with additional information from Gene Ontology, protein-protein interaction and signal transduction pathway databases in order to discover novel therapeutic pathways and targets. Genes involved in cell cycle regulation, the extracellular matrix, and in immunological responses are relevant to epithelial ovarian cancer biology and particular genes might have the potential to be exploited as therapeutic targets for small molecules, biologicals, and immunologicals. We hope to accomplish that the scope of the review which includes a discussion of the recently published papers and the implications of the results for the clinical management of EOC is of help to researchers and clinicians in the field.
Keywords: Epithelial ovarian cancer, tumour of low malignant potential, ascites, comparative genomic hybridisation, gene expression profiling, microarray, signal transduction pathway, diagnostic marker, therapeutic target
Current Genomics
Title: Gene Expression Profiling of Epithelial Ovarian Cancer
Volume: 7 Issue: 2
Author(s): Anette Sommer, Felix Hilpert and Norbert Arnold
Affiliation:
Keywords: Epithelial ovarian cancer, tumour of low malignant potential, ascites, comparative genomic hybridisation, gene expression profiling, microarray, signal transduction pathway, diagnostic marker, therapeutic target
Abstract: Gene expression profiling using microarrays and SAGE is a widely used technology to elucidate important aspects of epithelial ovarian cancer (EOC) in order to improve the clinical management of this disease: Despite the high degree of morphological heterogeneity, epithelial ovarian cancer gene expression profiling reflects morphology and biological behaviour. Based on multiple studies, gene expression profiling results can be used to stratify the four different subtypes of EOC, namely serous papillary, mucinous, endometrioid, and clear cell carcinoma, but some overlapping gene expression was also noted. An aneuploid DNA content is a frequent phenomenon in EOC as well as in other solid tumours. However, when differential RNA expression and the DNA copy number as measured by comparative genomic hybridisation (CGH) were compared, the level of concordance was not significant in most studies. The reason for this will mostly lie in the low resolving power of currently used CGH methods and might improve with a wider access to arrayCGH. Several novel candidate markers for the early detection of EOC have been identified by gene expression profiling and examples that have been validated by ELISA on the protein level in serum from EOC patients and healthy controls are discussed. The information from gene expression profiling experiments is now being overlaid with additional information from Gene Ontology, protein-protein interaction and signal transduction pathway databases in order to discover novel therapeutic pathways and targets. Genes involved in cell cycle regulation, the extracellular matrix, and in immunological responses are relevant to epithelial ovarian cancer biology and particular genes might have the potential to be exploited as therapeutic targets for small molecules, biologicals, and immunologicals. We hope to accomplish that the scope of the review which includes a discussion of the recently published papers and the implications of the results for the clinical management of EOC is of help to researchers and clinicians in the field.
Export Options
About this article
Cite this article as:
Sommer Anette, Hilpert Felix and Arnold Norbert, Gene Expression Profiling of Epithelial Ovarian Cancer, Current Genomics 2006; 7 (2) . https://dx.doi.org/10.2174/138920206777304641
DOI https://dx.doi.org/10.2174/138920206777304641 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Evidence-Based Management of Infertile Couples with Repeated Implantation Failure Following IVF
Current Women`s Health Reviews Modulation of Cytotoxicity of Benzamide Riboside by Expression of NMN Adenylyltransferase
Current Medicinal Chemistry Store-Dependent Ca2+ Entry in Endothelial Progenitor Cells As a Perspective Tool to Enhance Cell-Based Therapy and Adverse Tumour Vascularization
Current Medicinal Chemistry Cellular Senescence in the Development and Treatment of Cancer
Current Pharmaceutical Design Exercise-Induced Overexpression of Angiogenic Factors and Reduction of Ischemia / Reperfusion Injury in Stroke
Current Neurovascular Research A Critical Transcription Factor NF-κB as a Cancer Therapeutic Target and its Inhibitors as Cancer Treatment Options
Current Medicinal Chemistry Immunotherapeutic Options for Pediatric Malignancies
Current Immunology Reviews (Discontinued) Current Trends in the Chemotherapy of Colorectal Cancer
Current Medicinal Chemistry Targeting Angiogenic Pathways in Colorectal Cancer: Complexities, Challenges and Future Directions
Current Drug Targets Investigation of Isoindolo[2,1-a]quinoxaline-6-imines as Topoisomerase I Inhibitors with Molecular Modeling Methods
Current Computer-Aided Drug Design Nanoparticle-Based Tumor Theranostics with Molecular Imaging
Current Pharmaceutical Biotechnology MicroRNAs as Regulators in Normal Hematopoietic and Leukemia Stem Cells: Current Concepts and Clinical Implications
Current Molecular Medicine The Expression, Function and Targeting of Haem Oxygenase-1 in Cancer
Current Cancer Drug Targets Recent Advances in the Development of Immunoadhesins for Immune Therapy and as Anti-Infective Agents
Recent Patents on Anti-Infective Drug Discovery Therapeutic Potential of Autotaxin/Lysophospholipase D Inhibitors
Current Drug Targets Estrogen-Induced Genetic Alterations and Their Role in Carcinogenicity
Current Genomics Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation
Current Cancer Drug Targets Fluid-fluid Levels in Musculoskeletal Tumor Imaging
Current Medical Imaging HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cells
Mini-Reviews in Medicinal Chemistry